Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of Helicobacter pylori in Peptic Ulcer Disease
Background/AimsThe resistance rate of Helicobacter pylori is gradually increasing. We aimed to evaluate the efficacy of levofloxacin-based third-line H. pylori eradication in peptic ulcer disease.Methods : Between 2002 and 2014, 110 patients in 14 medical centers received levofloxacin-based third-li...
Збережено в:
| Автори: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Gastroenterology Council for Gut and Liver
2017-03-01
|
| Серія: | Gut and Liver |
| Предмети: | |
| Онлайн доступ: | http://gutnliver.org/journal/view.html?doi=10.5009/gnl16099 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
